Lisdexamfetamine, commonly known as Vyvanse, is a scheduled drug approved in Canada for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals and people. The medication functions as a https://apo-lisdexamfetamine-pri079027.iyublog.com/42166324/lisdexamfetamine-in-canada-a-full-overview